Cite
HARVARD Citation
Wegrzyn, P. et al. (n.d.). Development of selective MELK kinase inhibitors for breast cancer treatment. European journal of cancer. pp. S148-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wegrzyn, P. et al. (n.d.). Development of selective MELK kinase inhibitors for breast cancer treatment. European journal of cancer. pp. S148-. [Online].